FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293051489> ?p ?o ?g. }

• W4293051489 endingPage "565" @default.
• W4293051489 startingPage "555" @default.
• W4293051489 abstract "Some individuals develop type 2 diabetes mellitus (T2DM) despite significant metabolic improvements through lifestyle intervention. We tested the hypotheses that insulin growth factor 1 (IGF1) and its binding proteins 1 and 2 predict the onset of T2DM in prediabetes patients and determine the capacity for metabolic regeneration.We measured fasting serum IGF1, insulin growth factor-binding protein 1 (IGFBP1) and IGFBP2 in three randomized controlled lifestyle intervention trials, covering at least 1 year of intervention period and 1 year of additional follow-up.Within a sample of 414 high-risk prediabetes patients (58% women; 28-80 years), we analyzed fasting serum concentrations of IGF1, IGFBP1 and IGFBP2 in relation to diabetes incidence and metabolic parameters over 2 years. Three hundred and forty-five subjects finished the first year of intervention.The interventions significantly improved body weight (BMI: -3.24%, P < 0.001), liver fat (-36.8%, P < 0.001), insulin sensitivity (IS) (homeostatic model assessment-insulin resistance: -6.3%, P < 0.001) and insulin secretion (disposition index: +35%, P < 0.001) in the cohort. Fourteen percent developed T2DM within 2 years. Mean IGFBP1 levels at baseline were lower in prediabetes compared to a healthy population. Also, prediabetes patients with obesity and nonalcoholic fatty liver disease had lower IGFBP1. Those with impaired glucose tolerance had higher IGFBP1 compared to those with only impaired fasting glucose. Baseline IGF1 was lower (122.5 vs 146.6 µg/L) and IGFBP1 was higher (3.32 vs 2.09 µg/L) in subjects who developed T2DM (n = 57), resulting in a significant prediction of diabetes incidence (hazard ratio (HR) IGF1: 0.991 µg/L, P = 0.003; HR IGFBP1: 1.061 µg/L, P = 0.002). This translates into a 20% and 9% difference in T2DM incidence for IGF1 and IGFBP1, respectively. Despite reduced weight, visceral fat and hepatic fat in response to 1 year of lifestyle intervention, those who developed T2DM had not improved insulin sensitivity, glucose tolerance or IGFBP1.Lower IGF1 and higher IGFBP1 in prediabetes predicted the incidence of T2DM, indicating an impairment of beta-cell function, which explains the unresponsiveness to lifestyle intervention." @default.
• W4293051489 created "2022-08-25" @default.
• W4293051489 creator A5013839934 @default.
• W4293051489 creator A5015192785 @default.
• W4293051489 creator A5052449194 @default.
• W4293051489 creator A5052864107 @default.
• W4293051489 creator A5054318441 @default.
• W4293051489 creator A5057177496 @default.
• W4293051489 creator A5059770937 @default.
• W4293051489 creator A5061377061 @default.
• W4293051489 creator A5072373235 @default.
• W4293051489 creator A5072631237 @default.
• W4293051489 creator A5073898242 @default.
• W4293051489 creator A5077683516 @default.
• W4293051489 creator A5083798788 @default.
• W4293051489 date "2022-09-19" @default.
• W4293051489 modified "2023-10-01" @default.
• W4293051489 title "Low IGF1 and high IGFBP1 predict diabetes onset in prediabetic patients" @default.
• W4293051489 cites W1967237278 @default.
• W4293051489 cites W1975453845 @default.
• W4293051489 cites W1986962882 @default.
• W4293051489 cites W1995646241 @default.
• W4293051489 cites W1996849098 @default.
• W4293051489 cites W2003946235 @default.
• W4293051489 cites W2014798423 @default.
• W4293051489 cites W2015908877 @default.
• W4293051489 cites W2023300718 @default.
• W4293051489 cites W2036466897 @default.
• W4293051489 cites W2043194719 @default.
• W4293051489 cites W2044425469 @default.
• W4293051489 cites W2063014525 @default.
• W4293051489 cites W2077808397 @default.
• W4293051489 cites W2080778772 @default.
• W4293051489 cites W2087071824 @default.
• W4293051489 cites W2100548432 @default.
• W4293051489 cites W2110124224 @default.
• W4293051489 cites W2113094205 @default.
• W4293051489 cites W2119990476 @default.
• W4293051489 cites W2121879147 @default.
• W4293051489 cites W2123908001 @default.
• W4293051489 cites W2126590177 @default.
• W4293051489 cites W2127984332 @default.
• W4293051489 cites W2128538351 @default.
• W4293051489 cites W2133795831 @default.
• W4293051489 cites W2139334074 @default.
• W4293051489 cites W2140997600 @default.
• W4293051489 cites W2144449728 @default.
• W4293051489 cites W2154953463 @default.
• W4293051489 cites W2160234571 @default.
• W4293051489 cites W2160452185 @default.
• W4293051489 cites W2172039680 @default.
• W4293051489 cites W2342167938 @default.
• W4293051489 cites W2424236546 @default.
• W4293051489 cites W2512359502 @default.
• W4293051489 cites W2606709873 @default.
• W4293051489 cites W2773791657 @default.
• W4293051489 cites W2792266948 @default.
• W4293051489 cites W2829907285 @default.
• W4293051489 cites W2896916348 @default.
• W4293051489 cites W2898600258 @default.
• W4293051489 cites W2899982133 @default.
• W4293051489 cites W3014481020 @default.
• W4293051489 cites W3135086097 @default.
• W4293051489 cites W3200458596 @default.
• W4293051489 doi "https://doi.org/10.1530/eje-22-0034" @default.
• W4293051489 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36005859" @default.
• W4293051489 hasPublicationYear "2022" @default.
• W4293051489 type Work @default.
• W4293051489 citedByCount "3" @default.
• W4293051489 countsByYear W42930514892022 @default.
• W4293051489 countsByYear W42930514892023 @default.
• W4293051489 crossrefType "journal-article" @default.
• W4293051489 hasAuthorship W4293051489A5013839934 @default.
• W4293051489 hasAuthorship W4293051489A5015192785 @default.
• W4293051489 hasAuthorship W4293051489A5052449194 @default.
• W4293051489 hasAuthorship W4293051489A5052864107 @default.
• W4293051489 hasAuthorship W4293051489A5054318441 @default.
• W4293051489 hasAuthorship W4293051489A5057177496 @default.
• W4293051489 hasAuthorship W4293051489A5059770937 @default.
• W4293051489 hasAuthorship W4293051489A5061377061 @default.
• W4293051489 hasAuthorship W4293051489A5072373235 @default.
• W4293051489 hasAuthorship W4293051489A5072631237 @default.
• W4293051489 hasAuthorship W4293051489A5073898242 @default.
• W4293051489 hasAuthorship W4293051489A5077683516 @default.
• W4293051489 hasAuthorship W4293051489A5083798788 @default.
• W4293051489 hasConcept C126322002 @default.
• W4293051489 hasConcept C134018914 @default.
• W4293051489 hasConcept C2777180221 @default.
• W4293051489 hasConcept C2777185836 @default.
• W4293051489 hasConcept C2777391703 @default.
• W4293051489 hasConcept C2778535154 @default.
• W4293051489 hasConcept C2779306644 @default.
• W4293051489 hasConcept C2779668308 @default.
• W4293051489 hasConcept C2780609358 @default.
• W4293051489 hasConcept C2908647359 @default.
• W4293051489 hasConcept C555293320 @default.
• W4293051489 hasConcept C71924100 @default.
• W4293051489 hasConcept C99454951 @default.

• next